Exceeding Your Benchmark – Benchmark Products
Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…
Latest
Benchmark Products
Sterile Compounding and Contamination Control with Abby Roth
In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…
Benchmark Products
One Year of The Exceeding Your Benchmark Podcast
Benchmark Products provides products for critical life science and pharma environments. In this podcast series Exceeding Your Benchmark, they interview leading experts on a variety of trending topics. In celebration of its first year, Exceeding Your Benchmark looks back at interviews with experts from life science and pharmaceutical manufacturing on timely topics from Annex…
Exceeding Your Benchmark - Benchmark Products
Exploring the Fundamentals of Validation in Life Science Manufacturing
In the rapidly evolving domain of life science manufacturing, validation emerges as a cornerstone to ensure that products meet stipulated requirements concerning quality, safety, and efficacy. This pivotal aspect of manufacturing comes to focus as regulatory landscapes shift, mandating stringent compliance to ensure patient safety. In a recent episode of Exceeding Your Benchmark, a…
Articles Healthcare
Pharmaceutical Manufacturing is Witnessing Major Transformation as New Demands for Sterility Assurance Reshape Healthcare
For an industry where precision and quality control are paramount, pharmaceutical manufacturing is witnessing an evolutionary leap in contamination control practices. Propelled by changes in regulatory environments, such as the EU’s Annex 1 update and ICH Q9 focusing on quality risk management, the sector is shifting from isolated, data-point-centric strategies towards a more holistic…
Exceeding Your Benchmark - Benchmark Products
Connecting Data to Improve Your Contamination Control Strategies
Contamination control is absolutely critical in the pharmaceutical industry and includes particulate, microbial, product carryover, chemical, and viral aspects of contamination and often involves proactive, reactive, and supporting aspects. However, regulations, liabilities, and patient health added to the mix create data silos that often form multiple processes and make it difficult to create efficient and…
Exceeding Your Benchmark - Benchmark Products
Revolutionizing the Audit Process: Advancements in Supplier Assessments Within the Pharmaceutical Sector
Pharmaceutical companies invest significant resources in research and development to discover new drugs and therapies and improve existing ones. This involves rigorous testing, clinical trials, and obtaining regulatory approval before a drug can be sold. Government agencies, such as the Food and Drug Administration (FDA) in the United States, oversee the approval process and conduct…
Latest
Colleges Turn to Precision Marketing, Advanced Tracking, and Privacy-First Strategies to Engage Stealth Students
Colleges and universities face mounting challenges in reaching prospective students who never formally identify themselves in the recruitment process—often called “stealth shoppers.” Research shows that at least one in three applicants to private four-year colleges in the U.S. apply as stealth students. For enrollment leaders, this hidden audience—students who research institutions anonymously online before ever…
How to End UGC Self-Sabotage in B2B with Vidlo’s Chynna Morgan
Most B2B marketers already know user-generated content (UGC) has power. But too many still get in their own way — clinging to polished video shoots, siloed workflows, or the excuse that their brand “isn’t sexy.” In the latest episode of UGC for B2B, host Daniel Litwin sits down with Chynna Morgan, CEO & Founder…
How Hotels Bounce Back From the Unexpected
In this episode of Inside Restoration & Recovery, host Martha Lewis sits down with Josh Creznic, Director of Hospitality Services at BMS CAT, to unpack the unique challenges and critical priorities in hotel restoration. With over two decades of experience in hospitality—spanning major brands like Marriott and Wyndham—Josh brings deep insight into how restoration…
Built from the Dirt Up: Dillan Dumont’s Journey from Bricklayer to Industry Disruptor
With all types of infrastructure across America aging, there has never been more of a need for smarter, less disruptive solutions than now. From trenchless pipe repair to utility innovation, the construction world is shifting and young leaders like Dillan Dumont are stepping into the spotlight. Cities like New York and Chicago are facing…
